Twin Tree Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.33M Buy
+42,200
New +$9.21M 0.19% 106
2025
Q4
– Sell
-45,000
Closed -$12.3M – 1678
2025
Q3
$12.3M Sell
45,000
-96,400
-68% -$26.3M 0.05% 425
2025
Q2
$36.5M Buy
+141,400
New +$33.7M 0.07% 286
2025
Q1
– Sell
-26,900
Closed -$6.15M – 1871
2024
Q4
$6.15M Sell
26,900
-138,500
-84% -$33.3M 0.01% 864
2024
Q3
$40.4M Sell
165,400
-112,900
-41% -$25.2M 0.08% 209
2024
Q2
$53.3M Buy
+278,300
New +$56.5M 0.12% 156
2022
Q3
– Sell
-18,400
Closed -$3.86M – 1667
2022
Q2
$3.86M Hold
18,400
– – 0.01% 947
2022
Q1
$4.46M Buy
+18,400
New +$4.45M 0.01% 960
2021
Q3
– Sell
-44,700
Closed -$11M – 1738
2021
Q2
$11M Sell
44,700
-35,600
-44% -$7.48M 0.03% 483
2021
Q1
$15.6M Buy
80,300
+48,300
+151% +$9.7M 0.06% 340
2020
Q4
$6.8M Sell
32,000
-189,700
-86% -$37.8M 0.03% 536
2020
Q3
$38M Buy
221,700
+8,300
+4% +$1.53M 0.16% 140
2020
Q2
$41M Buy
213,400
+169,500
+386% +$27.7M 0.17% 146
2020
Q1
$6.47M Sell
43,900
-9,100
-17% -$1.45M 0.03% 424
2019
Q4
$8.21M Sell
53,000
-81,400
-61% -$11.7M 0.03% 398
2019
Q3
$18.2M Buy
+134,400
New +$17.6M 0.07% 199

Other funds holding RMD

Twin Tree Management's RMD Position: Q3 2026 in Review

Twin Tree Management opened a new position in ResMed (RMD) in Q3 2026: 5,518 shares worth $1.22M. The stake represents 0.03% of the portfolio and ranks #687 among its holdings. This is a return to the name: Twin Tree Management previously reported a position in RMD as recently as Q1 2025.

Twin Tree Management first reported a position in RMD in Q4 2015 and has held it in 22 quarters since. The position peaked at $22.6M in Q4 2023. 886 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Twin Tree Management held 5,518 shares of ResMed worth $1.22M as of Q3 2026.
  • ResMed was a new Twin Tree Management position in Q3 2026.
  • ResMed made up 0.03% of Twin Tree Management's portfolio in Q3 2026, its #687 holding.
  • Twin Tree Management first reported a position in ResMed in Q4 2015 and has held it in 22 quarters since.
  • Twin Tree Management's ResMed position peaked at $22.6M in Q4 2023.
  • 886 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Twin Tree Management's 13F filing for Q3 2026, filed 10 Nov 2026.